Detergent-activated BAX Protein Is a Monomer

BAX is a pro-apoptotic member of the BCL-2 protein family. At the onset of apoptosis, monomeric, cytoplasmic BAX is activated and translocates to the outer mitochondrial membrane, where it forms an oligomeric pore. The chemical mechanism of BAX activation is controversial, and several in vitro and in vivo methods of its activation are known. One of the most commonly used in vitro methods is activation with detergents, such as n-octyl glucoside. During BAX activation with n-octyl glucoside, it has been shown that BAX forms high molecular weight complexes that are larger than the combined molecular weight of BAX monomer and one detergent micelle. These large complexes have been ascribed to the oligomerization of BAX prior to its membrane insertion and pore formation. This is in contrast to the in vivo studies that suggest that active BAX inserts into the outer mitochondrial membrane as a monomer and then undergoes oligomerization. Here, to simultaneously determine the molecular weight and the number of BAX proteins per BAX-detergent micelle during detergent activation, we have used an approach that combines two single-molecule sensitivity technique, fluorescence correlation spectroscopy, and fluorescence-intensity distribution analysis. We have tested a range of detergents as follows: n-octyl glucoside, dodecyl maltoside, Triton X-100, Tween 20, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid, and cholic acid. With these detergents we observe that BAX is a monomer before, during, and after interaction with micelles. We conclude that detergent activation of BAX is not congruent with oligomerization and that in physiologic buffer conditions BAX can assume two stable monomeric conformations, one inactive and one active.BAX² is a pro-apoptotic member of the BCL-2 protein family. In a simplified apoptosis model, monomeric inactive BAX is localized in the cytoplasm of healthy nondying cells (1). During apoptosis BAX is activated and translocates to the outer mitochondrial membrane (2) where it inserts as a monomer (3), undergoes oligomerization (4), and forms a pore through which cytochrome c and other apoptotic factors are released into the cytoplasm. Once in the cytoplasm, these apoptotic factors induce the activation of the effector caspases that execute the cell death process. This mechanism, which is generally correct, requires that soluble BAX becomes integrated into the mitochondrial membrane where it forms a functional oligomeric pore capable of cytochrome c release. However, the molecular mechanism of BAX activation remains controversial (5, 6).It has been understood for some time, but frequently ignored, that activity of the BCL-2 family proteins is exhibited in cells when these proteins are associated with the hydrophobic environment of membranes. Therefore, it has always seemed that attention to the effect of hydrophobic environments on the BCL-2 family proteins would be rewarding. It has been shown that BAX can be directly activated by treatment with nonionic detergents such as n-octyl glucoside, dodecyl maltoside, and Triton X-100 (1, 7). During activation by nonionic detergents, to gain the ability to form pores in a bilayer membrane, BAX needs to undergo a major conformational transition from a globular protein with two pore-forming α-helices 5 and 6 hidden in the protein core (8) to a conformation in which these two helices are exposed and inserted into a lipid membrane (3, 5, 9). The nature of this active conformation of BAX is important for the understanding of the death decision in cells. Most proposals suggest that in a cell this activated form of BAX protein is initiated and maintained by the interactions with other proteins, such as tBID, or by BAX itself as a homo-oligomer (7, 10).Nonionic detergents have been commonly used to activate BAX for in vitro studies because they are reliably effective and simple to employ. However, little is known about the detailed molecular mechanism of BAX activation by these detergents and its comparability with in vivo activation of BAX. What is known is that concentrations of detergent above their critical micelle concentration (CMC) are necessary for BAX activation. This suggests that, to be activated, BAX needs to interact with detergent micelles instead of monomeric detergent molecules. For example, in the case of BAX activation by n-octyl glucoside, it has been shown that n-octyl glucoside concentration should be 1% (w/v) (7), which is well above the CMC for this detergent (0.6% w/v) (11). In addition, it has also been shown that above their individual CMC concentrations most BAX-activating detergents produce a change in BAX conformation that can be detected by a conformation-sensitive 6A7 antibody against BAX (1, 12, 13). In cellular experiments this feature of BAX reactivity to 6A7 antibody is commonly associated with the onset of apoptosis (14, 15). However, CHAPS does not generate the antibody-detected conformational change or the activation of BAX. The small micelle size of this detergent (10 kDa) suggests that perhaps BAX cannot adopt an activated state with this detergent. However, cholic acid with even smaller micelle size (4 kDa) can partially activate BAX (1).Many important detergent properties are associated with micelles. The formation of detergent micelles in solution is concentration-dependent beginning at the CMC. The CMC value for a detergent has practical importance because in most cases only monomers of detergent can be removed by dialysis, and therefore, it is easier to remove detergent monomers for a detergent with high CMC value than for a detergent with low CMC (11). For BAX this same consideration applies to its activation with n-octyl glucoside (CMC ∼23 mm) as compared with its activation with Triton X-100 (CMC ∼0.25 mm). The ease of dialysis is why, in most cases, OG is used to activate BAX in vitro.It has been shown by analytical gel filtration that, when incubated with n-octyl glucoside, BAX creates complexes with molecular weight larger than the combined size of a BAX monomer (21 kDa) and an n-octyl glucoside micelle (∼26 kDa) (7, 11). It has also been shown that in defined liposomes BAX pore formation requires oligomerization (16). These data combined with the knowledge that oligomerization is important for the biological function of BAX led to a hypothesis that BAX oligomerizes during its detergent activation prior to membrane insertion (7). However, it has been shown that in vivo activated BAX inserts into the outer mitochondrial membrane as a monomer (3), and to create a pore, BAX undergoes oligomerization in this membrane (4). This discrepancy between the oligomeric state of active BAX prior to its insertion into a lipid membrane in vivo (monomer) and in vitro (possibly hexamer or octamer) led us to study the oligomerization state of BAX in detergent micelles. The important issue is whether BAX activation requires protein oligomerization or whether active BAX conformation can be generated from a single protein monomer. To solve this issue we used two single-molecule sensitivity techniques: fluorescence correlation spectroscopy (FCS) (17) and fluorescence-intensity distribution analysis (FIDA) (18). Combined use of FCS and FIDA allows simultaneous determination of the apparent molecular weight and the number of fluorescently labeled BAX monomers per protein-detergent micelle. Our results are consistent with previously established results in which BAX forms high molecular weight protein-detergent micelles with n-octyl glucoside (4) and show that BAX is present as a monomer in these complexes. In addition, we determined the apparent molecular weight and the number of BAX proteins bound per protein-detergent micelles formed by BAX and micelles of five additional detergents (dodecyl maltoside, Triton X-100, Tween 20, cholic acid, and CHAPS). Our data show that BAX is a monomer before, during, and after interaction with the micelles of all tested detergents.     

Repetitive DNA sequences located in the central region of the human mdr1 (multidrug resistance) gene may account for a gene fusion event during its evolution

The mdr1 gene, first member of the human multidrug-resistance gene family, is a major gene involved in cellular resistance to several drugs used in anticancer chemotherapy. Its product, the drug-excreting P-glycoprotein, shows a bipartite structure formed by two similar adjacent halves. According to one hypothesis, the fusion of two related ancestral genes during evolution could have resulted in this structure. The DNA sequence analysis of the introns located in the region connecting the two halves of the human mdr1 gene revealed a highly conserved poly(CA) · poly (TG) sequence in intron 15 and repeated sequences of the Alu family in introns 14 and 17. These repeated sequences most likely represent molecular fossils of ancient DNA elements which were involved in such a recombination event. Correspondence to: M. Pauly     

Structural basis for the high-affinity interaction of nidogen-1 with immunoglobulin-like domain 3 of perlecan

Nidogen and perlecan are large multifunctional basement membrane (BM) proteins conserved in all metazoa. Their high-affinity interaction, which is likely to contribute to BM assembly and function, is mediated by the central G2 domain in nidogen and the third immunoglobulin (IG)-like domain in perlecan, IG3. We have solved the crystal structure at 2.0 A resolution of the mouse nidogen-1 G2-perlecan IG3 complex. Perlecan IG3 belongs to the I-set of the IG superfamily and binds to the wall of the nidogen-1 G2 beta-barrel using beta-strands C, D and F. Nidogen-1 residues participating in the extensive interface are highly conserved, whereas the corresponding binding site on perlecan is more variable. We hypothesize that a second, as yet unidentified, activity of nidogen overlaps with perlecan binding and accounts for the unusually high degree of surface conservation in the G2 domain.     

Ten Years after the International Committee of Medical Journal Editors’ Clinical Trial Registration Initiative,One Quarter of Phase 3 Pediatric Epilepsy Clinical Trials Still Remain Unpublished: A Cross Sectional Analysis

Introduction

Although selective reporting of clinical trial results introduces bias into evidence based clinical decision making, publication bias in pediatric epilepsy is unknown today. Since there is a considerable ambiguity in the treatment of an important and common clinical problem, pediatric seizures, we assessed the public availability of results of phase 3 clinical trials that evaluated treatments of seizures in children and adolescents as a surrogate for the extent of publication bias in pediatric epilepsy.

Methods

We determined the proportion of published and unpublished study results of phase 3 clinical trials that were registered as completed on ClinicalTrials.gov. We searched ClinicalTrials.gov, PubMed, and Google Scholar for publications and contacted principal investigators or sponsors. The analysis was performed according to STROBE criteria.

Results

Considering studies that were completed before 2014 (N = 99), 75 (76%) pediatric phase 3 clinical trials were published but 24 (24%) remained unpublished. The unpublished studies concealed evidence from 4,437 patients. Mean time-to-publication was 25 SD ± 15.6 months, more than twice as long as mandated.

Conclusion

Ten years after the ICMJE’s clinical trials registration initiative there is still a considerable amount of selective reporting and delay of publication that potentially distorts the body of evidence in the treatment of pediatric seizures.     

A Phytotoxic Glycopeptide from Cultures of Corynebacterium insidiosum

Cultures of Corynebacterium insidiosum produce an extra-cellular phytotoxic glycopeptide that possesses the ability to wilt plant cuttings. Wilt induced by this glycopeptide is directly dependent upon time and upon concentration with measureable wilt occurring in 40 nm solutions in 1 hour. The organism produces 1.3 grams toxin/liter of culture medium. The toxin was purified, and the physical, chemical, and biological properties were measured. The glycopeptide has an empirical formula of C₁₀₈H₂₂₆O₁₃₂N based on 1 atom of nitrogen. The molecular weight as estimated by light scattering and column gel chromatography indicated values approximating 5 × 10⁶. The toxin does not dissociate into small molecular weight subunits when treated with 8 m urea or 30% pyridine.     

Effect of simazine on nitrate reductase activity in corn

The nutritional and environmental parameters required for eliciting increases in the nitrogen content and growth of corn (Zea mays L.) by non-toxic levels of simazine have been established. Corn seedlings with the endosperm removed 10 days after germination, proved to be a suitable test species. The addition of simazine to the root-zone area of corn plants grown under both sub-optimal temperatures and low nitrate levels, increased the nitrogen content and dry weight of the plants by 20 to 25%. This increase was found to be associated with an effect on nitrate reductase.     

Triacontanol and Its Second Messenger 9-beta-l(+)-Adenosine as Plant Growth Substances

Triacontanol (TRIA), a common constituent of plant waxes, was first shown in 1977 to be an active growth substance which at nanomolar concentrations increased the growth and yield of crops. TRIA is used to increase crop yields on millions of hectares, particularly in Asia. Many investigators have shown that it affects several basic metabolic processes including photosynthesis, nutrient uptake, and enzyme activity. However, the initial site of action has not been elucidated. TRIA rapidly elicits a second messenger (TRIM) in rice (Oryza sativa L.), which at nanomolar concentrations causes plants to respond in a manner similar to TRIA. TRIM has been identified as 9-β-l(+)-adenosine (9H-purin-6-amine, 9-β-l-ribofuranosyl). During the process of isolating and identifying 9-β-l(+)-adenosine, it was shown that this enantiomer, which previously has not been reported as occurring in nature, made up about 1% of the total adenosine pool in roots from untreated rice seedlings.     

Study of the carbohydrate part of yeast acid phosphatase

It has been found that the carbohydrate part of acid phosphatase from yeast Saccharomyces cerevisiae consists of 16 N-glycosidically linked carbohydrate chains containing from 14 to about 150 mannose units. The presence of very small amounts of O-glycosidically linked chains was indicated. Acetolysis studies pointed to a high similarity in the structure of acid phosphatase and mannan carbohydrate chains. A new method is described for cross-linking of acid phosphatase specifically via carbohydrate chains. The possibility to cross-link the enzyme subunits intramolecularly is in accordance with the suggestion that carbohydrate chains play a role in subunit associations.     

Loss of p14ARF in tumor cells facilitates replication of the adenovirus mutant dl1520 (ONYX-015)

The adenovirus mutant dl1520 (ONYX-015) does not express the E1B-55K protein that binds and inactivates p53. This virus replicates in tumor cells with mutant p53, but not in normal cells with functional p53. Although intra-tumoral injection of dl1520 shows promising responses in patients with solid tumors, previous in vitro studies have not established a close correlation between p53 status and dl1520 replication. Here we identify loss of p14ARF as a mechanism that allows dl1520 replication in tumor cells retaining wild-type p53. We demonstrate that the re-introduction of p14ARF into tumor cells with wild-type p53 suppresses replication of dl1520 in a p53-dependent manner. Our study supports the therapeutic use of dl1520 in tumors with lesions within the p53 pathway other than mutation of p53.